| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 3 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9AGA4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 54 | 58 | PF00656 | 0.622 |
| CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.428 |
| CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.345 |
| DEG_APCC_DBOX_1 | 72 | 80 | PF00400 | 0.309 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.688 |
| DOC_CYCLIN_RxL_1 | 28 | 37 | PF00134 | 0.617 |
| DOC_MAPK_MEF2A_6 | 73 | 82 | PF00069 | 0.466 |
| DOC_MAPK_NFAT4_5 | 73 | 81 | PF00069 | 0.414 |
| DOC_PP4_FxxP_1 | 47 | 50 | PF00568 | 0.639 |
| DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.716 |
| LIG_14-3-3_CanoR_1 | 35 | 42 | PF00244 | 0.625 |
| LIG_14-3-3_CanoR_1 | 73 | 79 | PF00244 | 0.380 |
| LIG_Actin_WH2_2 | 22 | 37 | PF00022 | 0.629 |
| LIG_FHA_1 | 4 | 10 | PF00498 | 0.662 |
| LIG_FHA_2 | 17 | 23 | PF00498 | 0.651 |
| LIG_FHA_2 | 25 | 31 | PF00498 | 0.586 |
| LIG_FHA_2 | 52 | 58 | PF00498 | 0.625 |
| LIG_LIR_Gen_1 | 62 | 72 | PF02991 | 0.570 |
| LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.580 |
| LIG_PCNA_yPIPBox_3 | 56 | 68 | PF02747 | 0.551 |
| LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.641 |
| LIG_SH3_3 | 47 | 53 | PF00018 | 0.667 |
| LIG_WW_2 | 50 | 53 | PF00397 | 0.591 |
| MOD_CK2_1 | 16 | 22 | PF00069 | 0.653 |
| MOD_CK2_1 | 24 | 30 | PF00069 | 0.590 |
| MOD_CK2_1 | 34 | 40 | PF00069 | 0.522 |
| MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.455 |
| MOD_NEK2_1 | 24 | 29 | PF00069 | 0.636 |
| MOD_NEK2_1 | 34 | 39 | PF00069 | 0.550 |
| MOD_NEK2_1 | 68 | 73 | PF00069 | 0.562 |
| MOD_PKA_2 | 34 | 40 | PF00069 | 0.621 |
| MOD_Plk_1 | 59 | 65 | PF00069 | 0.568 |
| MOD_Plk_4 | 59 | 65 | PF00069 | 0.587 |
| MOD_Plk_4 | 74 | 80 | PF00069 | 0.401 |
| MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.715 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8I949 | Leishmania donovani | 100% | 100% |
| A4H6S3 | Leishmania braziliensis | 72% | 100% |
| E9ACR2 | Leishmania major | 88% | 100% |
| E9ANT4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |